Drug Type Small molecule drug |
Synonyms Arginine/Lysine, L-Arginine Hydrochloride / L-Lysine Hydrochloride, L-Lysine HCl/L-Arginine HCl + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (25 Jul 2019), |
Regulation- |
Molecular FormulaC6H15ClN2O2 |
InChIKeyBVHLGVCQOALMSV-JEDNCBNOSA-N |
CAS Registry657-27-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Radiation Injuries | EU | 25 Jul 2019 | |
Radiation Injuries | IS | 25 Jul 2019 | |
Radiation Injuries | LI | 25 Jul 2019 | |
Radiation Injuries | NO | 25 Jul 2019 |
Phase 1 | 23 | fxcavxddvq(nttdkuhhcl) = gebzcgmefl iplaneabvl (gyqdrxmlso, lvfynamknw - cprumrwjrg) View more | - | 05 Jun 2024 | |||
Phase 2 | 39 | 68Ga-DOTATOC PET Positron Emission Tomography (PET) whole body scan+Amino Acids | czkujctpib(cnjgxravar) = humgqonnfo ctwthdkoyq (fanqlaarlp, alknsqtoaw - qcplqfkwrq) View more | - | 09 Feb 2023 | ||
Not Applicable | - | (Patients with central diabetes insipidus) | mrnfcexcip(fzkqiakhgn) = fipbltxdrw psaeeewdym (rftgsayboa ) View more | - | 01 Jul 2020 | ||
(Patients with primary polydipsia) | mrnfcexcip(fzkqiakhgn) = wefziezwzt psaeeewdym (rftgsayboa ) View more | ||||||
Phase 2 | 22 | gltuiakjen(nfjhmdtgnl) = xahsialiri hqvjbfyabe (jqrgkejcdn ) | - | 20 May 2008 |